Description

Sculptor (Ostarine + Andarine S4) – Product Information

Sculptor is a combination of two selective androgen receptor modulators (SARMs): Ostarine (MK-2866) and Andarine (S4). SARMs are a class of compounds that has the potential to interact with androgen receptors, leading to potential anabolic effects on muscles and bones, similar to anabolic compounds but with fewer potential androgenic side effects.

The combination of Ostarine and Andarine is believed to have synergistic effects, as they target different androgen receptors and pathways. Ostarine is known for its potential in preserving lean muscle mass and aid in muscle recovery, while Andarine is believed to have similar muscle-preserving properties along with potential benefits in enhancing muscle hardness and strength.

• Sculptor consist of Ostarine and Andarine S4.
• Ostarine liquid is offered in 33mg per ml for 30 ml, totaling 1000mg.
• Andarine S4 liquid is offered in 53mg per ml for 30ml, totaling 1600mg.

Ostarine (MK-2866)

Ostarine (MK-2866) stands out as a leading research compound dedicated to preserving lean muscle mass effectively. Originally developed to combat muscle-wasting diseases, Ostarine has demonstrated remarkable potential in this area. Studies reveal its selective binding to androgen receptors, leading to beneficial effects on muscle structure and metabolism in ovariectomized rats. Additionally, Ostarine has been shown to enhance muscle vascularization in these rats, opening exciting possibilities for investigating its ability to safeguard lean muscle tissue during a caloric deficit. The extensive promise of Ostarine in research paves the way for further exploration into its muscle-preserving capabilities.

Andarine S4

Andarine, also known as S4, is an investigational SARM that has been studied for its potential effects on muscle and bone. It has shown promise in research for its ability to selectively bind to androgen receptors, which can lead to anabolic effects on muscle tissue and bone density.

In 2005, a scientific study investigated the impact of Andarine S-4 on the skeletal muscles, bones, and pituitary glands of castrated male rats. The study administered a treatment protocol of 3 and 10mg/kg S4-Andarine for 8 weeks, starting 12 weeks after castration. Remarkably, Andarine at both 3 and 10 mg/kg doses restored soleus muscle mass and strength, as well as levator ani muscle mass, to levels similar to those observed prior to castration or in intact animals.

These findings highlight Andarine S4 as a promising Selective Androgen Receptor Modulator (SARM) with potential implications in treating conditions related to muscle wasting, osteoporosis, and benign prostatic hyperplasia (BPH). By mimicking many of the beneficial pharmacologic effects linked to testosterone, S4 holds promise as an investigational therapeutic option in these areas.